GUCY1A1

Across TCGA pan-cancer cohorts, GUCY1A1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated GUCY1A1 data layer compared with 24 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher GUCY1A1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated GUCY1A1 expression acts as an unfavorable survival marker, although some lineages such as PDAC and CCRCC show a favorable association.

PDAC, CCRCC, and LUAD are the cancer types where GUCY1A1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	OS	Median	II,III,IV	0.463	0.275	.003	34	view →
CCRCC	DFS	Tertile	III,IV	0.660	0.367	.033	9	view →
LUAD	DFS	Median	All	0.755	0.479	.001	7	view →
LSCC	OS	Quartile	All	0.612	1.000	.043	4	view →
HNSC	DFS	Quartile	III,IV	1.000	0.876	.041	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

GUCY1A1–PDAC (OS)

Open the PDAC breakdown →